Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome
- PMID: 28246611
- PMCID: PMC5303582
- DOI: 10.1155/2017/9624702
Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome
Abstract
The aim of our study was to compare patients with irritable bowel syndrome (IBS) and healthy controls regarding the expression of toll-like receptors 2, 4, 5, and 9 (TLR2, TLR4, TLR5, and TLR9), the primary mucosal receptors of bacterial components, in small and large bowel mucosa. Methods. We analysed biopsies from jejunum and sigmoid colon of 22 patients (17 females) with IBS aged 18-66 (median: 39) years and 14 healthy volunteers (12 females) aged 22-61 (median: 42) years. Eight patients had constipation-predominant IBS (C-IBS), 7 had diarrhoea-predominant IBS (D-IBS), and 7 had IBS without predominance of constipation or diarrhoea. We analysed mRNA levels for TLRs using quantitative PCR and distribution of TLRs in mucosa using immunohistochemistry. Results. We found increased mRNA expression of TLR4 (mean fold change 1.85 ± 0.31 versus 1.0 ± 0.20; p < 0.05), TLR5 (1.96 ± 0.36 versus 1.0 ± 0.20; p < 0.05) and TLR9 (2.00 ± 0.24 versus 1.0 ± 0.25; p < 0.01) but not of TLR2 in the small bowel mucosa from patients with IBS compared to the controls. There was no significant difference in mRNA levels for TLRs in colon mucosa between patients and controls. Conclusion. Upregulation of TLR4, TLR5, and TLR9 suggests the involvement of bacteria or dysregulation of the immune response to commensal flora in small bowel mucosa in IBS patients.
Conflict of interest statement
The authors have no competing interests to declare.
Figures




Similar articles
-
The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome.Intern Med. 2016;55(9):1043-8. doi: 10.2169/internalmedicine.55.5716. Epub 2016 May 1. Intern Med. 2016. PMID: 27150852
-
[Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome].Zhonghua Yi Xue Za Zhi. 2008 Dec 30;88(48):3415-7. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19159572 Chinese.
-
Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.BMC Gastroenterol. 2011 Dec 20;11:138. doi: 10.1186/1471-230X-11-138. BMC Gastroenterol. 2011. PMID: 22185629 Free PMC article.
-
Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis.Neurogastroenterol Motil. 2019 Dec;31(12):e13718. doi: 10.1111/nmo.13718. Epub 2019 Sep 9. Neurogastroenterol Motil. 2019. PMID: 31498961
-
Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.J Gastroenterol Hepatol. 2017 Jan;32(1):53-63. doi: 10.1111/jgh.13417. J Gastroenterol Hepatol. 2017. PMID: 27087165 Review.
Cited by
-
Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome.Oncotarget. 2017 Dec 8;8(69):113957-113965. doi: 10.18632/oncotarget.23045. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371960 Free PMC article.
-
Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome.World J Gastroenterol. 2022 Jan 28;28(4):412-431. doi: 10.3748/wjg.v28.i4.412. World J Gastroenterol. 2022. PMID: 35125827 Free PMC article. Review.
-
The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics.Biomolecules. 2024 Dec 21;14(12):1643. doi: 10.3390/biom14121643. Biomolecules. 2024. PMID: 39766350 Free PMC article. Review.
-
Gut microbiota and irritable bowel syndrome: status and prospect.Front Med (Lausanne). 2024 Oct 17;11:1429133. doi: 10.3389/fmed.2024.1429133. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39484201 Free PMC article. Review.
-
Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation.Am J Physiol Gastrointest Liver Physiol. 2022 Aug 1;323(2):G88-G101. doi: 10.1152/ajpgi.00063.2022. Epub 2022 May 3. Am J Physiol Gastrointest Liver Physiol. 2022. PMID: 35502856 Free PMC article.
References
-
- Taniguchi Y., Yoshioka N., Nakata K., et al. Mechanism for maintaining homeostasis in the immune system of the intestine. Anticancer Research. 2009;29(11):4855–4860. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources